Global Extracorporeal Blood Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2024

  • receipt Report ID : 157582
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 124
  • list Pharmaceuticals and Healthcare

The extracorporeal blood treatment is a type of filtration method used to remove many toxins from the blood.

Scope of the Report:

This report studies the Extracorporeal Blood Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Extracorporeal Blood Treatment market by product type and applications/end industries.

The demand for extracorporeal blood treatment is expected to upsurge owing to the growth of kidney diseases.

United States region dominated the extracorporeal blood treatment market owing to the presence of undisputed market players, the presence of strong research developments and presence of insurance coverage.

Economically developing region such as Asia Pacific is expected to be the fastest growing with the presence of huge population base and also an increase in the number of patient undergoing dialysis.

The global Extracorporeal Blood Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Extracorporeal Blood Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Fresenius Medical Care

DaVita Kidney Care

Renal Care

Dialysis Clinic

American Renal Associates

Satellite Healthcare

Atlantic Dialysis Management

Northwest Kidney Centers

Centers for Dialyssis Care

Rogosin Institute

B. Braun

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Hemodialysis

Acute dialysis

Apheresis 

Market Segment by Applications, can be divided into

Icu

Severe Sepsis

Acute Lung Injury

Liver Failure

Cardiogenic Shock

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Extracorporeal Blood Treatment Market Overview

1.1 Product Overview and Scope of Extracorporeal Blood Treatment

1.2 Classification of Extracorporeal Blood Treatment by Types

1.2.1 Global Extracorporeal Blood Treatment Revenue Comparison by Types (2017-2023)

1.2.2 Global Extracorporeal Blood Treatment Revenue Market Share by Types in 2017

1.2.3 Hemodialysis

1.2.4 Acute dialysis

1.2.5 Apheresis 

1.3 Global Extracorporeal Blood Treatment Market by Application

1.3.1 Global Extracorporeal Blood Treatment Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Icu

1.3.3 Severe Sepsis

1.3.4 Acute Lung Injury

1.3.5 Liver Failure

1.3.6 Cardiogenic Shock

1.4 Global Extracorporeal Blood Treatment Market by Regions

1.4.1 Global Extracorporeal Blood Treatment Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Extracorporeal Blood Treatment Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Extracorporeal Blood Treatment Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Extracorporeal Blood Treatment Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Extracorporeal Blood Treatment Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Extracorporeal Blood Treatment Status and Prospect (2013-2023)

1.5 Global Market Size of Extracorporeal Blood Treatment (2013-2023)

2 Manufacturers Profiles

2.1 Fresenius Medical Care

2.1.1 Business Overview

2.1.2 Extracorporeal Blood Treatment Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Fresenius Medical Care Extracorporeal Blood Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.2 DaVita Kidney Care

2.2.1 Business Overview

2.2.2 Extracorporeal Blood Treatment Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 DaVita Kidney Care Extracorporeal Blood Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.3 Renal Care

2.3.1 Business Overview

2.3.2 Extracorporeal Blood Treatment Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Renal Care Extracorporeal Blood Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.4 Dialysis Clinic

2.4.1 Business Overview

2.4.2 Extracorporeal Blood Treatment Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Dialysis Clinic Extracorporeal Blood Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.5 American Renal Associates

2.5.1 Business Overview

2.5.2 Extracorporeal Blood Treatment Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 American Renal Associates Extracorporeal Blood Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.6 Satellite Healthcare

2.6.1 Business Overview

2.6.2 Extracorporeal Blood Treatment Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Satellite Healthcare Extracorporeal Blood Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.7 Atlantic Dialysis Management

2.7.1 Business Overview

2.7.2 Extracorporeal Blood Treatment Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Atlantic Dialysis Management Extracorporeal Blood Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.8 Northwest Kidney Centers

2.8.1 Business Overview

2.8.2 Extracorporeal Blood Treatment Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Northwest Kidney Centers Extracorporeal Blood Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.9 Centers for Dialyssis Care

2.9.1 Business Overview

2.9.2 Extracorporeal Blood Treatment Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Centers for Dialyssis Care Extracorporeal Blood Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.10 Rogosin Institute

2.10.1 Business Overview

2.10.2 Extracorporeal Blood Treatment Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Rogosin Institute Extracorporeal Blood Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.11 B. Braun

2.11.1 Business Overview

2.11.2 Extracorporeal Blood Treatment Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 B. Braun Extracorporeal Blood Treatment Revenue, Gross Margin and Market Share (2016-2017)

3 Global Extracorporeal Blood Treatment Market Competition, by Players

3.1 Global Extracorporeal Blood Treatment Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Extracorporeal Blood Treatment Players Market Share

3.2.2 Top 10 Extracorporeal Blood Treatment Players Market Share

3.3 Market Competition Trend

4 Global Extracorporeal Blood Treatment Market Size by Regions

4.1 Global Extracorporeal Blood Treatment Revenue and Market Share by Regions

4.2 North America Extracorporeal Blood Treatment Revenue and Growth Rate (2013-2018)

4.3 Europe Extracorporeal Blood Treatment Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Extracorporeal Blood Treatment Revenue and Growth Rate (2013-2018)

4.5 South America Extracorporeal Blood Treatment Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Extracorporeal Blood Treatment Revenue and Growth Rate (2013-2018)

5 North America Extracorporeal Blood Treatment Revenue by Countries

5.1 North America Extracorporeal Blood Treatment Revenue by Countries (2013-2018)

5.2 USA Extracorporeal Blood Treatment Revenue and Growth Rate (2013-2018)

5.3 Canada Extracorporeal Blood Treatment Revenue and Growth Rate (2013-2018)

5.4 Mexico Extracorporeal Blood Treatment Revenue and Growth Rate (2013-2018)

6 Europe Extracorporeal Blood Treatment Revenue by Countries

6.1 Europe Extracorporeal Blood Treatment Revenue by Countries (2013-2018)

6.2 Germany Extracorporeal Blood Treatment Revenue and Growth Rate (2013-2018)

6.3 UK Extracorporeal Blood Treatment Revenue and Growth Rate (2013-2018)

6.4 France Extracorporeal Blood Treatment Revenue and Growth Rate (2013-2018)

6.5 Russia Extracorporeal Blood Treatment Revenue and Growth Rate (2013-2018)

6.6 Italy Extracorporeal Blood Treatment Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Extracorporeal Blood Treatment Revenue by Countries

7.1 Asia-Pacific Extracorporeal Blood Treatment Revenue by Countries (2013-2018)

7.2 China Extracorporeal Blood Treatment Revenue and Growth Rate (2013-2018)

7.3 Japan Extracorporeal Blood Treatment Revenue and Growth Rate (2013-2018)

7.4 Korea Extracorporeal Blood Treatment Revenue and Growth Rate (2013-2018)

7.5 India Extracorporeal Blood Treatment Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Extracorporeal Blood Treatment Revenue and Growth Rate (2013-2018)

8 South America Extracorporeal Blood Treatment Revenue by Countries

8.1 South America Extracorporeal Blood Treatment Revenue by Countries (2013-2018)

8.2 Brazil Extracorporeal Blood Treatment Revenue and Growth Rate (2013-2018)

8.3 Argentina Extracorporeal Blood Treatment Revenue and Growth Rate (2013-2018)

8.4 Colombia Extracorporeal Blood Treatment Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Extracorporeal Blood Treatment by Countries

9.1 Middle East and Africa Extracorporeal Blood Treatment Revenue by Countries (2013-2018)

9.2 Saudi Arabia Extracorporeal Blood Treatment Revenue and Growth Rate (2013-2018)

9.3 UAE Extracorporeal Blood Treatment Revenue and Growth Rate (2013-2018)

9.4 Egypt Extracorporeal Blood Treatment Revenue and Growth Rate (2013-2018)

9.5 Nigeria Extracorporeal Blood Treatment Revenue and Growth Rate (2013-2018)

9.6 South Africa Extracorporeal Blood Treatment Revenue and Growth Rate (2013-2018)

10 Global Extracorporeal Blood Treatment Market Segment by Type

10.1 Global Extracorporeal Blood Treatment Revenue and Market Share by Type (2013-2018)

10.2 Global Extracorporeal Blood Treatment Market Forecast by Type (2018-2023)

10.3 Hemodialysis Revenue Growth Rate (2013-2023)

10.4 Acute dialysis Revenue Growth Rate (2013-2023)

10.5 Apheresis  Revenue Growth Rate (2013-2023)

11 Global Extracorporeal Blood Treatment Market Segment by Application

11.1 Global Extracorporeal Blood Treatment Revenue Market Share by Application (2013-2018)

11.2 Extracorporeal Blood Treatment Market Forecast by Application (2018-2023)

11.3 Icu Revenue Growth (2013-2018)

11.4 Severe Sepsis Revenue Growth (2013-2018)

11.5 Acute Lung Injury Revenue Growth (2013-2018)

11.6 Liver Failure Revenue Growth (2013-2018)

11.7 Cardiogenic Shock Revenue Growth (2013-2018)

12 Global Extracorporeal Blood Treatment Market Size Forecast (2018-2023)

12.1 Global Extracorporeal Blood Treatment Market Size Forecast (2018-2023)

12.2 Global Extracorporeal Blood Treatment Market Forecast by Regions (2018-2023)

12.3 North America Extracorporeal Blood Treatment Revenue Market Forecast (2018-2023)

12.4 Europe Extracorporeal Blood Treatment Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Extracorporeal Blood Treatment Revenue Market Forecast (2018-2023)

12.6 South America Extracorporeal Blood Treatment Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Extracorporeal Blood Treatment Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Extracorporeal Blood Treatment Picture

Table Product Specifications of Extracorporeal Blood Treatment

Table Global Extracorporeal Blood Treatment and Revenue (Millio

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery